论文部分内容阅读
目的:观察金双歧联合思密达治疗小儿腹泻的临床治疗效果。方法:将我院2011年2月-2013年2月收治的106例小儿腹泻患儿随机分为观察组和对照组,每组各53例,对照组给予口服思密达,观察组在此基础上加用金双歧,两组均治疗3d后对比疗效。结果:观察组的总有效率96.23%,显著高于对照组77.36%,p<0.05差异具有统计学意义,两组患儿治疗期间均未发生不良反应。结论:金双歧联合思密达治疗小儿腹泻疗效显著,不良反应少,值得临床推广应用。
Objective: To observe the clinical effect of Jinshuangqi combined with Smecta for treating infantile diarrhea. Methods: A total of 106 children with infantile diarrhea who were admitted to our hospital from February 2011 to February 2013 were randomly divided into observation group and control group, with 53 cases in each group. Oral Smectite was given to the control group, On the increase of gold bifidobacterium, two groups were treated 3d after comparison. Results: The total effective rate in the observation group was 96.23%, which was significantly higher than that in the control group (77.36%). The difference was statistically significant at p <0.05. No adverse reactions occurred in both groups during treatment. Conclusion: Jinshuangqi combined with Smectite treatment of children with diarrhea significant effect, fewer adverse reactions, worthy of clinical application.